Acupuncture Can Regulate the Distribution of Lymphocyte Subsets and the Levels of Inflammatory Cytokines in Patients With Mild to Moderate Vascular Dementia

Hui Zhi, Yao Wang, Shichen Chang, Pan Pan, Zhenzhen Ling, Zhen Zhang, Zhinan Ma, Runmin Wang, Xuezhu ZhangFrontiers in Aging Neuroscience 2021 · DOI

Abstract

Background: Vascular dementia (VD) is the second most common type of dementia, yet definitive treatments remain limited. Recent evidence suggests that peripheral immune dysfunction and systemic inflammation exacerbate neuroinflammation and cognitive decline in VD. Objective: This study aimed to evaluate the effect of the "sanjiao" acupuncture method on the peripheral immune profiles of patients with mild to moderate VD. Methods: A controlled trial involved 30 VD patients (Acupuncture Group, AG) and 30 healthy controls (Normal Group, NG). The AG received "sanjiao" acupuncture for 12 weeks. Lymphocyte subsets and cytokine levels were measured using flow cytometry (FCM) and ELISA. Results: Before treatment, VD patients exhibited significantly lower levels of CD3+ T cells, CD4+ T cells, and Tregs, alongside elevated TNF-α. Following 12 weeks of acupuncture, CD3+ and CD4+ T cell proportions and IFN-γ levels increased, while TNF-α levels significantly decreased. Treg proportions also improved. Conclusion: Acupuncture modulates peripheral immune function by regulating T-cell distribution and reducing pro-inflammatory cytokines, suggesting a systemic anti-inflammatory mechanism for its therapeutic effects in VD.

Introduction

Vascular dementia (VD) arises from chronic cerebral hypoperfusion, leading to progressive cognitive impairment. Beyond localized brain damage, the role of the peripheral immune system in driving neuroinflammation has gained prominence. Patients with VD often present with a compromised blood-brain barrier and an imbalance in circulating immune cells and signaling proteins (cytokines). While acupuncture is a recognized complementary therapy for VD, its specific impact on these systemic immune markers has not been extensively documented. This study investigates whether the "sanjiao" acupuncture method can restore immune homeostasis in VD patients.

Methods

The study recruited 60 participants: 30 patients with mild-to-moderate VD and 30 healthy elderly controls. The Acupuncture Group (AG) underwent the "sanjiao" protocol, targeting specific acupoints once daily, six days a week, for 12 weeks.

Figure 1: Research flowchart illustrating the study design and participant progression.

Immune profiling was conducted via:

  1. Flow Cytometry (FCM): To quantify lymphocyte subsets, including CD3+, CD4+, and CD8+ T-cells, and Regulatory T-cells (Tregs).
  2. ELISA: To measure concentrations of cytokines such as TNF-α (pro-inflammatory), IFN-γ (immunostimulatory), and IL-10 (anti-inflammatory).

Results

Baseline Immune Deficits in VD

Initial assessments revealed that VD patients suffered from systemic immunodepression. Compared to the healthy control group, patients in the AG had significantly lower baseline levels of CD3+ T cells, CD4+ T cells, B cells, and Tregs. Conversely, levels of the pro-inflammatory cytokine TNF-α were significantly elevated, highlighting a state of chronic systemic inflammation.

Immunomodulatory Effects of Acupuncture

After the 12-week intervention, the AG showed significant improvements across several key immune markers:

  • T-Cell Populations: Proportions of CD3+ and CD4+ T-cells increased significantly ($P < 0.05$).
  • Regulatory T-Cells: The proportion of Tregs, which act as "peacekeepers" to prevent excessive inflammation, saw a significant boost ($P < 0.01$).
Figure 3: Flow cytometry gating strategy used to identify regulatory T-cells (Tregs) in peripheral blood.
  • Cytokine Profile Shift: TNF-α levels dropped significantly ($P < 0.01$), while IFN-γ levels increased ($P < 0.01$), suggesting a shift toward a more balanced and vigorous immune response.
  • Specificity: No significant changes were observed in B cell or Natural Killer (NK) cell populations, indicating that the "sanjiao" method specifically targets T-cell-mediated pathways.

Discussion

The findings suggest that acupuncture acts as a potent immunomodulator in VD. By increasing the population of protective T-cells and Tregs while simultaneously reducing the pro-inflammatory burden (TNF-α), acupuncture may help mitigate the peripheral drivers of neuroinflammation. TNF-α is particularly noteworthy as it is closely linked to hippocampal atrophy and cognitive decline; its reduction provides a clear biochemical rationale for acupuncture's clinical benefits.

Conclusion

The "sanjiao" acupuncture method effectively regulates the distribution of lymphocyte subsets and inflammatory cytokines in patients with mild to moderate VD. These results provide biological evidence that acupuncture's benefits for dementia may be mediated through the restoration of peripheral immune function and the reduction of systemic inflammation.

Summary updated

Abstract

<b>Background:</b> Vascular dementia (VD) is the second most common type of dementia after Alzheimer's disease, but there is a lack of definitive treatment for VD. Acupuncture treatment is effective in improving the cognitive impairment and behavioral capacity of patients with VD. In recent years, more studies indicated that peripheral inflammation and abnormal peripheral immune function may aggravate neuroinflammation and cognitive dysfunction. However, there are few studies about the acupuncture and the abnormal peripheral immune function of VD. Also, few studies concern the regulating effect of acupuncture on peripheral immunity of patients with VD. <b>Objective:</b> The aim of this study was to explore the effect of the "sanjiao" acupuncture method on peripheral immunity of patients with mild to moderate VD. <b>Methods:</b> A total of 30 patients with VD were involved in the acupuncture group (AG), which was treated with the "sanjiao" acupuncture method once a day for six times a week and lasted for 12 weeks, and 30 healthy elderly people were assigned to the normal group (NG), which had no treatment. The distribution of lymphocyte subsets and the levels of some inflammatory cytokines in the peripheral blood of subjects were evaluated using the flow cytometry (FCM) and the enzyme-linked immunosorbent assay (ELISA). <b>Results:</b> A total of 60 subjects were involved in this study, while 58 subjects completed the entire trial. Before treatment, the levels of CD3<sup>+</sup> T, CD4<sup>+</sup> T cells, CD4<sup>+</sup>/CD8<sup>+</sup>, Tregs, B cells, IFN-γ, and IL-10 in patients with VD were significantly decreased compared with the normal group (all <i>P</i> < 0.05 or <i>P</i> < 0.01). The level of TNF-α in peripheral blood of patients with VD was significantly increased (<i>P</i> < 0.01). After acupuncture treatment, the levels of CD3<sup>+</sup> T, CD4<sup>+</sup> T cells, and IFN-γ were significantly increased (all <i>P</i> < 0.05 or <i>P</i> < 0.01). The level of TNF-α was significantly decreased (<i>P</i> < 0.01). The proportion of Tregs was increased (<i>P</i> < 0.01), but it was still lower than that of the normal group (<i>P</i> < 0.05). <b>Conclusion:</b> The acupuncture method can increase the proportion of CD3<sup>+</sup>, CD4<sup>+</sup> T cells, and Tregs in peripheral blood of patients with VD. And, it reduces the levels of pro-inflammatory factor TNF-α, which achieves the anti-inflammatory effects and immunostimulation. It suggests that acupuncture can improve the peripheral immune dysfunction of patients with VD by regulating the distribution of lymphocyte subsets and the levels of inflammatory cytokines. <b>Clinical Trial Registration:</b> [www.chictr.org.cn], identifier [ChiCTR-IOR-17012052].
BibTeX
@inproceedings{zhi2021acupuncture,
  author = {Hui Zhi and Yao Wang and Shichen Chang and Pan Pan and Zhenzhen Ling and Zhen Zhang and Zhinan Ma and Runmin Wang and Xuezhu Zhang},
  title = {{Acupuncture Can Regulate the Distribution of Lymphocyte Subsets and the Levels of Inflammatory Cytokines in Patients With Mild to Moderate Vascular Dementia}},
  booktitle = {Frontiers in Aging Neuroscience},
  year = {2021},
  doi = {10.3389/fnagi.2021.747673},
}
Figure